This website uses cookies to ensure you get the best experience.

LabGenius and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best experience of it. If you consent to it, we will also use cookies for analytics and marketing purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking “Manage cookies” at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor

These cookies are used to make advertising messages more relevant to you. In some cases, they also deliver additional functions on the site.

Vendors Vimeo
Skip to main content
LabGenius
Department

Lead Discovery

Connect

 

The Display Technologies team uses in vitro recombinant technologies such as phage display as a powerful platform for the discovery of candidates suitable for drug development. We enable the identification of a broad range of biologics, including antibodies, with the ability to engineer many of the attributes of successful drugs. We generate highly diverse display libraries and build machine-learning designed libraries.

Recent projects include reducing our reliance on out-sourced phage display work by generating our own in-house novel phage and ML designed libraries.


 

About LabGenius

Headquartered in London, LabGenius Therapeutics is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.

 

Founded in 2012
Co-workers 60

Already working at LabGenius?

Let’s recruit together and find your next colleague.

Career site by Teamtailor